Technology News and Research

RSS

GlycoVaxyn initiates Phase I clinical study of GVXN SD133 vaccine candidate against Shigella dysenteriae

GlycoVaxyn, a pioneer in the development of innovative bioconjugate vaccines, has commenced a Phase I clinical study with its vaccine candidate (GVXN SD133) against Shigella dysenteriae, a cause of serious intestinal infections. This is the first product from the company to enter clinical evaluation.

23 Feb 2010

Head and neck tumors in close proximity to sensitive areas may lead to brain injury, visionary risk or hearing loss

When head and neck tumors - from sinus tumors to acoustic neuromas attached to the hearing and balance nerve at the base of the skull - are located in close proximity to such sensitive areas such as the brain and eyes, they are particularly dangerous due to possible brain injury, visionary risk or hearing loss.

23 Feb 2010

New cardiac imaging technique reduces radiation exposure compared to standard helical scan

In a new study published in the March issue of Radiology, researchers from Columbia University and the National Heart, Lung and Blood Institute have determined that an imaging exam of the heart using the latest generation of CT technology exposes patients to as much as 91 percent less radiation than standard helical CT scanning.

23 Feb 2010

Aetna selects Millennium Laboratories as national pain management services provider

Millennium Laboratories, a leading provider of therapeutic drug monitoring and education to physicians and staff treating chronic pain patients, announced today a national agreement with Aetna, one of the nation’s leading diversified health care benefits companies that serves approximately 36.3 million people. Under the terms of the three-year ancillary services agreement which went into effect February 1, 2010, Millennium Laboratories’ will assist Aetna participating physicians nationwide with state-of-the-art therapeutic drug monitoring services and tools.

23 Feb 2010

Viamet Pharmaceuticals, Novartis Option Fund partner to develop novel inhibitors against key metalloenzyme target

Viamet Pharmaceuticals, Inc. announced today that it has entered into a licensing option agreement with the Novartis Option Fund. Under terms of the agreement, Viamet will utilize its proprietary Metallophile™ Technology to discover and develop novel metalloenzyme inhibitors against a specific metalloenzyme of high interest to Novartis. The agreement includes an upfront fee and potential milestones totaling over $200 million as well as product royalties.

23 Feb 2010

Varian Medical Systems wins 100th X-ray tube patent

Varian Medical Systems, Inc., a premier supplier of X-ray tubes and flat panel digital image detectors, announced it has been awarded a patent for improved shielding in X-ray tubes. It is the company's 100th X-ray tube patent from the United States Patent Office.

23 Feb 2010

Kb Port launches innovative tool for storing and cataloging multiple ETC recordings

Kb Port LLC, an innovative multimedia solutions provider, is proud to announce the availability of its ETC Archiver. For current and future users of Kb Port’s powerful ETC Technology, the Archiver represents a breakthrough for clients who store and catalog multiple ETC recordings. It’s an advance in technology that, once again, distinguishes Kb Port in the medical simulation industry.

23 Feb 2010

Pulmonx to raise new funding for global launch of Zephyr EBV and Chartis Pulmonary Assessment System

Pulmonx, an emerging leader in interventional pulmonology, announced today that it has concluded an agreement for a new round of equity financing from an investment syndicate led by two new investors. The company also announced that it plans to use this capital to support the international commercial launch of its Zephyr® Endobronchial Valve (EBV), and its recently approved Chartis® Pulmonary Assessment System. Both products are CE marked and cleared for sale in Europe and other major international markets.

23 Feb 2010

Melamine-contaminated dairy products leave 12% children with kidney abnormalities

While the majority of children who were affected by consuming toxic melamine-contaminated products in China recovered, kidney abnormalities remained in 12% of the affected children.

23 Feb 2010

Research reveals human Chlamydia pneumoniae has originated from animal source

Animals have been found to have infected humans sometime in the past with the common respiratory disease Chlamydia pneumoniae, according to Queensland University of Technology infectious disease expert Professor Peter Timms.

23 Feb 2010

Venza Group to demonstrate just-in-time healthcare solutions at HIMSS Conference

The Venza Group's Instructional Designers worked closely with client-side subject matter experts to create the eGuides, and the industry-leading Venza eGuide rapid development tool was used to build them. In the end, 69 eGuides totaling 571 screens and 1,071 steps were generated. The overall project was completed in a timely manner to the complete satisfaction of all concerned.

23 Feb 2010

SciCan forms merger with SycoTec, MICRO-MEGA to create dental equipment companies group

SciCan, a Toronto based manufacturer of infection control products and solutions with subsidiaries in Canonsburg PA, Augsburg Germany and Zug Switzerland has merged with dental manufacturer SycoTec (previously, EWL, a subsidiary of the KAVO Group located in Leutkirch Germany) and French endodontic specialist MICRO-MEGA (Besancon). SciCan, the worlds largest producer of table top autoclaves will be part of this strong company alliance under the leadership of SycoTec's Managing Partner Dr. Martin Rickert. Together the group will be one of the ten largest dental equipment manufacturers in the world of innovative products for the dental and medical markets.

23 Feb 2010

Memometal Technologies announces acquisition of ABS' OrthoGlide Ankle Technology

Memometal Technologies S.A., a global extremity orthopaedic manufacturer headquartered in France, announced today that it has completed the acquisition of all the assets of Advanced Bio-Surfaces (ABS) Corporation’s OrthoGlide® Ankle Technology.

23 Feb 2010

Heartware completes patient enrollment for ADVANCE clinical trial

HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies revolutionizing the treatment of advanced heart failure, today announced the conclusion of patient enrollment under its "ADVANCE" clinical trial.

23 Feb 2010

Study shows CEL-2000 vaccine blocks RA progression in mice

CEL-SCI Corporation and their scientific collaborators announced today that the Company's CEL-2000 vaccine demonstrated that it is able to block the progression of rheumatoid arthritis (RA) in a mouse model.

23 Feb 2010

FDA grants Haemonetics clearance to collect two RBC on Cymbal system

On January 27, 2010 the FDA cleared the Haemonetics 510(k) for its expanded nomogram to collect two Red Blood Cells on the Cymbal® Automated Blood Collection System from female donors who are at least 150 pounds and are 63 inches in height. The Cymbal is a small, portable, battery operated instrument that automates blood collection from volunteer donors, improving process control and helping alleviate blood shortages.

23 Feb 2010

Star Scientific seeks FDA marketing approval for Ariva-BDL dissolvable tobacco lozenge

Star Scientific, Inc. announced that on Friday, February 19 the company filed an application with the Food & Drug Administration for approval to market Ariva-BDL™ as a "modified risk" tobacco product under the Family Smoking Prevention and Tobacco Control Act of 2009. This submission is the first such application to be filed with the Tobacco Products Center of the FDA, which has been established to oversee all aspects of tobacco regulation outlined in the 2009 Act.

23 Feb 2010

UCI researchers create new breed of flightless mosquitoes for dengue control

UCI researchers and colleagues from Oxitec Ltd. and the University of Oxford created the new breed. Flightless females are expected to die quickly in the wild, curtailing the number of mosquitoes and reducing - or even eliminating - dengue transmission. Males of the strain can fly but do not bite or convey disease.

23 Feb 2010

Agilent Technologies wins breach of contract case against Advanced Materials Technology

Agilent Technologies Inc. today announced a favorable decision in its trade secrets and breach of contract case against Advanced Materials Technology, Inc. (AMT) and three of its employees in the Delaware Court of Chancery. Agilent filed the lawsuit in January 2008 to protect confidential and proprietary information relating to its high-performance liquid chromatography technology.

23 Feb 2010

LFB Biotechnologies provides new loan financing to GTC Biotherapeutics for key strategic programs

GTC Biotherapeutics, Inc. (“GTC”, NASDAQ: GTCB) announced that it has entered into an agreement with its strategic partner, LFB Biotechnologies (Les Ulis, France), pursuant to which LFB has agreed to provide $7 million of new loan financing to GTC.

23 Feb 2010

Technology News and Research

GlycoVaxyn initiates Phase I clinical study of GVXN SD133 vaccine candidate against Shigella dysenteriae

Head and neck tumors in close proximity to sensitive areas may lead to brain injury, visionary risk or hearing loss

New cardiac imaging technique reduces radiation exposure compared to standard helical scan

Aetna selects Millennium Laboratories as national pain management services provider

Viamet Pharmaceuticals, Novartis Option Fund partner to develop novel inhibitors against key metalloenzyme target

Varian Medical Systems wins 100th X-ray tube patent

Kb Port launches innovative tool for storing and cataloging multiple ETC recordings

Pulmonx to raise new funding for global launch of Zephyr EBV and Chartis Pulmonary Assessment System

Melamine-contaminated dairy products leave 12% children with kidney abnormalities

Research reveals human Chlamydia pneumoniae has originated from animal source

Venza Group to demonstrate just-in-time healthcare solutions at HIMSS Conference

SciCan forms merger with SycoTec, MICRO-MEGA to create dental equipment companies group

Memometal Technologies announces acquisition of ABS' OrthoGlide Ankle Technology

Heartware completes patient enrollment for ADVANCE clinical trial

Study shows CEL-2000 vaccine blocks RA progression in mice

FDA grants Haemonetics clearance to collect two RBC on Cymbal system

Star Scientific seeks FDA marketing approval for Ariva-BDL dissolvable tobacco lozenge

UCI researchers create new breed of flightless mosquitoes for dengue control

Agilent Technologies wins breach of contract case against Advanced Materials Technology

LFB Biotechnologies provides new loan financing to GTC Biotherapeutics for key strategic programs

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News